FNA
Price
$13.09
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
998.19M
54 days until earnings call
MASS
Price
$6.95
Change
+$0.27 (+4.04%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
227.41M
67 days until earnings call
Interact to see
Advertisement

FNA vs MASS

Header iconFNA vs MASS Comparison
Open Charts FNA vs MASSBanner chart's image
Paragon 28
Price$13.09
Change-$0.00 (-0.00%)
Volume$19.38M
Capitalization998.19M
908 Devices
Price$6.95
Change+$0.27 (+4.04%)
Volume$3.95K
Capitalization227.41M
FNA vs MASS Comparison Chart
Loading...
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FNA vs. MASS commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNA is a StrongBuy and MASS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (FNA: $13.09 vs. MASS: $6.68)
Brand notoriety: FNA and MASS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FNA: 129% vs. MASS: 110%
Market capitalization -- FNA: $998.19M vs. MASS: $227.41M
FNA [@Medical Specialties] is valued at $998.19M. MASS’s [@Medical Specialties] market capitalization is $227.41M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FNA’s FA Score shows that 0 FA rating(s) are green whileMASS’s FA Score has 0 green FA rating(s).

  • FNA’s FA Score: 0 green, 5 red.
  • MASS’s FA Score: 0 green, 5 red.
According to our system of comparison, both FNA and MASS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MASS’s TA Score shows that 5 TA indicator(s) are bullish.

  • MASS’s TA Score: 5 bullish, 4 bearish.

Price Growth

FNA (@Medical Specialties) experienced а 0.00% price change this week, while MASS (@Medical Specialties) price change was +14.27% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.10%. For the same industry, the average monthly price growth was +5.33%, and the average quarterly price growth was +1.79%.

Reported Earning Dates

FNA is expected to report earnings on Jul 30, 2025.

MASS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+2.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FNA($998M) has a higher market cap than MASS($227M). MASS YTD gains are higher at: 203.864 vs. FNA (26.718). FNA has higher annual earnings (EBITDA): -26.92M vs. MASS (-34.03M). MASS has more cash in the bank: 146M vs. FNA (75.6M). MASS has less debt than FNA: MASS (5.95M) vs FNA (110M). FNA has higher revenues than MASS: FNA (216M) vs MASS (50.2M).
FNAMASSFNA / MASS
Capitalization998M227M440%
EBITDA-26.92M-34.03M79%
Gain YTD26.718203.86413%
P/E Ratio370.37N/A-
Revenue216M50.2M430%
Total Cash75.6M146M52%
Total Debt110M5.95M1,850%
TECHNICAL ANALYSIS
Technical Analysis
MASS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DISRX24.06N/A
N/A
BNY Mellon International Stock Fund I
SWANX23.51N/A
N/A
Schwab Core Equity
HRCCX28.45N/A
N/A
Carillon ClariVest Capital Apprec C
MELAX15.38N/A
N/A
Morgan Stanley Inst EMkts Ldrs A
LHCFX18.38N/A
N/A
Lord Abbett Health Care F

FNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, FNA has been loosely correlated with TMCI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FNA jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FNA
1D Price
Change %
FNA100%
N/A
TMCI - FNA
42%
Loosely correlated
+0.17%
GMED - FNA
35%
Loosely correlated
-0.18%
NPCE - FNA
34%
Loosely correlated
+0.53%
KIDS - FNA
33%
Poorly correlated
+3.63%
EXAS - FNA
32%
Poorly correlated
-1.45%
More